BIOCON:NSE
Biocon Ltd
၃၄၉.၂၀ ₹
arrow_downward
-၀.၈၀%(-၂.၈၀) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀ · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIOCON...
Open
၃၅၂.၆၀ ₹
High
၃၅၃.၀၀ ₹
Low
၃၄၈.၀၀ ₹
Mkt. cap
ဋေ ၅.၆၉ သ
Avg. vol.
၂.၉၇ သန်း
Volume
၁.၈၈ သန်း
Dividend
၀.၁၄%
Quarterly dividend
၀.၁၂ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၃
P/E ratio
၁၀၃.၃၈
52-wk high
၄၄၇.၁၅ ₹
52-wk low
၃၃၇.၇၀ ₹
EPS
၃.၃၈ ₹
Shares outstanding
၆၀.၀၀ ကုဋေ
No. of employees
၂ သောင်း
Open
၃၅၂.၆၀ ₹
High
၃၅၃.၀၀ ₹
Low
၃၄၈.၀၀ ₹
Mkt. cap
ဋေ ၅.၆၉ သ
Avg. vol.
၂.၉၇ သန်း
Volume
၁.၈၈ သန်း
Dividend
၀.၁၄%
Quarterly dividend
၀.၁၂ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၃
P/E ratio
၁၀၃.၃၈
52-wk high
၄၄၇.၁၅ ₹
52-wk low
၃၃၇.၇၀ ₹
EPS
၃.၃၈ ₹
Shares outstanding
၆၀.၀၀ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
Yahoo Finance
·
ပြီးခဲ့သည့် ၃၉ မိနစ်
Iambic Therapeutics (IAM) Joins The Nasdaq Composite, Is The Stock Already Pricey?
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၀ မိနစ်
MakeMyTrip (MMYT) Heads Into October Results With Fair Value Still In Focus
AOL.com
·
ပြီးခဲ့သည့် ၄၉ မိနစ်
Prediction: Oracle Stock Trails the S&P 500 Through 2030
MarketWatch
·
ပြီးခဲ့သည့် ၁ ရက်
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees၁.၆၄ သောင်း
Founded၁၉၇၈ နို ၂၉
Headquartersဘန်ဂလိုမြို့, ကာနာတာကာ, အိန္ဒိယ
Sector-
Websitebiocon.com